September 21, 2011
Wellesley, Mass. – In a recent release, POLYMERASE CHAIN REACTION (PCR) TECHNOLOGIES AND GLOBAL MARKETS (BIO087A) from BCC Research (www.bccresearch.com), the global PCR products market is expected to increase from nearly $5 billion in 2010 to nearly $8 billion in 2015 at an estimated compound annual growth rate (CAGR) of 9.9%.
The global PCR market can be broken down into four segments – reagents and consumables, instruments, software, and services.
The reagents and consumables segment accounted for the largest share at nearly $2.7 billion in 2010 and is expected to grow at a CAGR of 10.5% from 2010 to 2015.
The segment made up of instruments held a value of $1.7 billion in 2010 and is expected to increase at a CAGR of 9.6% to reach $2.7 billion in 2015.
The software segment was worth $337 million in 2010 and should be worth $503 million in 2015, a CAGR of 8.3%.
The segment made up of services, worth $238 million in 2010, should be worth $344 million in 2015, a CAGR of 7.7%.
PCR technology has enormous potential in the proteomics and genomics fields and has revolutionized the molecular and functional genomics sector due to its capability of rapid cloning, selective amplification of target DNA, and DNA analysis, including quantifying and analyzing DNA structure, gene expression, and metabolic pathways.
PCR technology has also contributed to the growing number of genomic studies comprising low- as well as high-density multiplex arrays for finding susceptibility of inherited disease, single-nucleotide polymorphism (SNP) analysis and genotyping, mRNA profiling, and microbial identification in the field of genomics.
Used in proteomics and genomics to create genome nucleotide sequences for exploring gene expressions under different environmental conditions, PCR helps researchers explore the development of disease and its response to environmental factors. Proteomics and genomics already form multibillion-dollar markets and also have high growth potential in the future. Increasing use of PCR, especially quantitative PCR (qPCR), will facilitate the growth of the PCR market in the long term.
This report will be most valuable to key decision makers such as CEOs, VPs, AVPs, marketing heads, research heads of the PCR manufacturers, technology providers, software providers, and service providers. It will also be useful to existing biotech instrumentation players looking to enter high-growth markets, as well as end users, such as healthcare, pharmaceutical companies, and drug discovery companies.
Polymerase Chain Reaction (PCR) Technologies and Global Markets( BIO087A )
Publish Date: Aug 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.